LAVA Therapeutics (LVTX)
NASDAQ:LVTX
Holding LVTX?
Track your performance easily

LAVA Therapeutics (LVTX) Financial Statements

154 Followers

LAVA Therapeutics Financial Overview

LAVA Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.908; its P/E ratio is -2.00; LAVA Therapeutics is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 15.26M$ 468.00K$ 1.00M
Gross Profit-----
EBIT--$ -1.51M$ -7.75M$ -10.33M
EBITDA--$ -1.34M$ -7.58M$ -10.16M
Net Income Common Stockholders--$ 997.00K$ -7.92M$ -10.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 95.57M$ 132.87M$ 92.72M$ 110.71M$ 124.16M
Total Assets$ 101.71M$ 143.43M$ 149.89M$ 115.31M$ 129.51M
Total Debt$ 6.31M$ 5.45M$ 4.63M$ 4.83M$ 5.10M
Net Debt$ -89.26M$ -127.42M$ -88.09M$ -105.88M$ -119.06M
Total Liabilities$ 50.53M$ 57.38M$ 57.23M$ 21.27M$ 21.10M
Stockholders Equity$ 51.18M$ 86.32M$ 92.66M$ 94.04M$ 108.41M
Cash Flow-
Free Cash Flow--$ -14.32M$ -9.74M$ -7.95M
Operating Cash Flow--$ -14.34M$ -9.72M$ -7.63M
Investing Cash Flow--$ 6.58M$ 3.53M$ 3.37M
Financing Cash Flow--$ -7.00K$ 36.00K$ 270.00K
Currency in USD

LAVA Therapeutics Earnings and Revenue History

LAVA Therapeutics Debt to Assets

LAVA Therapeutics Cash Flow

LAVA Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis